Treatment options for the management of chronic obstructive pulmonary disease.
- Published in:
- 2004
- By:
- Publication type:
- Journal Article
Works matching IS 1082801X AND DT 2004 AND VI 39 AND IP 11
Results: 27
1
2
Nebivolol: a beta antagonist with novel pharmacologic properties.
- Published in:
- 2004
- By:
- Publication type:
- Journal Article
3
Suit alleges FDA overstepped jurisdiction in regulating compounding pharmacies.
- Published in:
- Formulary, 2004, v. 39, n. 11, p. 558
- Publication type:
- Article
4
Selected literature.
- Published in:
- Formulary, 2004, v. 39, n. 11, p. 560
- Publication type:
- Article
5
Extended-release methylphenidate demonstrates greater improvement over atomoxetine in ADHD.
- Published in:
- Formulary, 2004, v. 39, n. 11, p. 528
- Publication type:
- Article
6
ASHP, AMCP recommend criteria for Medicare formulary design, formulary decision-maker responsibilities.
- Published in:
- Formulary, 2004, v. 39, n. 11, p. 559
- Publication type:
- Article
7
Atorvastatin lowers cholesterol, heart attack risk in patients with type 2 diabetes.
- Published in:
- Formulary, 2004, v. 39, n. 11, p. 525
- Publication type:
- Article
8
Hypertension and stroke.
- Published in:
- Formulary, 2004, v. 39, n. 11, p. 560
- Publication type:
- Article
9
Erlotinib prolongs survival of patients with NSCLC.
- Published in:
- Formulary, 2004, v. 39, n. 11, p. 529
- Publication type:
- Article
10
Illinois, Wisconsin specify safeguards, provisions in state-sponsored WWW prescription drug pharmacy.
- Published in:
- Formulary, 2004, v. 39, n. 11, p. 559
- Publication type:
- Article
11
Repaglinide improves blood glucose control in patients with type 2 diabetes.
- Published in:
- Formulary, 2004, v. 39, n. 11, p. 528
- Publication type:
- Article
12
Report lists steps to improve product quality regulatory system.
- Published in:
- Formulary, 2004, v. 39, n. 11, p. 558
- Publication type:
- Article
13
Oral capecitabine more efficacious than IV 5-FU/LV in treating colon cancer.
- Published in:
- Formulary, 2004, v. 39, n. 11, p. 529
- Publication type:
- Article
14
Drug and Formulary Trends.
- Published in:
- Formulary, 2004, v. 39, n. 11, p. 556
- Publication type:
- Article
15
Treatment options for the management of chronic obstructive pulmonary disease.
- Published in:
- Formulary, 2004, v. 39, n. 11, p. 542
- By:
- Publication type:
- Article
16
Nebivolol.
- Published in:
- Formulary, 2004, v. 39, n. 11, p. 532
- By:
- Publication type:
- Article
17
news in brief.
- Published in:
- Formulary, 2004, v. 39, n. 11, p. 530
- Publication type:
- Article
18
Darbepoetin alfa dosed every 2 weeks similar to weekly epoetin alfa in boosting Hb.
- Published in:
- Formulary, 2004, v. 39, n. 11, p. 530
- Publication type:
- Article
19
Tiered formulary copayment strata may affect participant drug choice.
- Published in:
- Formulary, 2004, v. 39, n. 11, p. 525
- Publication type:
- Article
20
Safety labeling updates & new warnings.
- Published in:
- Formulary, 2004, v. 39, n. 11, p. 524
- Publication type:
- Article
21
Oral contraceptive use may reduce risk of cardiovascular events, cancer.
- Published in:
- Formulary, 2004, v. 39, n. 11, p. 524
- Publication type:
- Article
22
FDA directs antidepressant manufacturers to add pediatric suicidality 'black box' warning to labeling.
- Published in:
- Formulary, 2004, v. 39, n. 11, p. 523
- Publication type:
- Article
23
Pharmacologic, lifestyle recommendations may reduce hyperkalemic risk caused by ACE inhibitors/ARBs.
- Published in:
- Formulary, 2004, v. 39, n. 11, p. 523
- Publication type:
- Article
24
First-time generic approvals.
- Published in:
- Formulary, 2004, v. 39, n. 11, p. 520
- Publication type:
- Article
25
Pipeline preview.
- Published in:
- Formulary, 2004, v. 39, n. 11, p. 520
- Publication type:
- Article
26
FDA actions in brief.
- Published in:
- Formulary, 2004, v. 39, n. 11, p. 519
- Publication type:
- Article
27
Abilify.
- Published in:
- Formulary, 2004, v. 39, n. 11, p. 519
- Publication type:
- Article